Ra Medical Systems Inc

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Catheter Precision, Inc. engages in the design, manufacture and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for accurate positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins in September 2002 and is headquartered in Fort Mill, SC.

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, today announced the closing of an underwritten public offering of units and pre-funded units for aggregate gross proceeds of approximately $12.1 million, prior to deducting underwriting discounts and commissions and offering expenses. The offering was comprised of (i) 9,535,000 units, priced at a public offering p

Ra Medical Systems, Inc. Announces Closing of $12.1 Million Underwritten Public Offering

Ra Medical Systems Inc  RMED has priced an underwritten public offering of 9.535 million units at $0.50 per unit for approximately $12.0 million in gross proceeds. Get the Inside Access Traders Are Using to Profit More and Win Bigger.

Why Are Ra Medical Shares Plunging to 52-Week Low?

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED--Ra Medical Systems announces pricing of $12.0 million underwritten public offering

Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #Atherectomy--Ra Medical Systems issued Letter to Stockholders.

Ra Medical Systems CEO Issues Letter to Stockholders

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q3 2021 Results - Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three and nine months ended September 30, 2021 and provides a business update. Recent Operational Highlights Completed the sale of the Pharos dermatology business for net cash proceeds of $3.5 million as part of the continued focus by the company of its resources on the large perip

Ra Medical Systems Reports 2021 Third Quarter Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report third quarter 2021 financial results after market close on Monday, November 15. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update. Pre-Registration   Participants can pre-register for the conference call here:           Callers who pre-register wi

Ra Medical Systems to Report Third Quarter 2021 Financial Results on November 15, 2021

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular diseases, announces that management will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. A webcast of the presentation will be available on the “News and Events” section of the company's website beginning Monday, September 13 at 7:00 a.m. Eastern time. About

Ra Medical Systems to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q2 2021 Results - Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing its excimer laser system to treat vascular disease, reports financial results for the three and six months ended June 30, 2021 and provides a business update. Recent Operational Highlights Announced the sale of the Pharos dermatology business as part of the continued focus by the company of its resources on the large peripheral artery disease (PAD) market Enrol

Ra Medical Systems Reports 2021 Second Quarter Financial Results

STRATA Skin Sciences

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing its excimer laser system to treat vascular disease, announces the sale of its Pharos dermatology business to STRATA Skin Sciences (Nasdaq: SSKN) for $3.7 million in cash. The Pharos excimer laser is FDA-cleared for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. “We believe this transaction is in the best interest of Ra Medical and our sh

Ra Medical Systems Announces Sale of Pharos Dermatology Business

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report second quarter 2021 financial results after market close on Monday, August 16, 2021. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update. Pre-Registration Participants can pre-register for the conference call here:     Callers who pre-register will

Ra Medical Systems to Report Second Quarter 2021 Financial Results on August 16, 2021

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #PAD--Ra Medical Systems Announces Progress with Guidewire-Compatible Catheter Design and Provides Update on Atherectomy Trial Enrollment

Ra Medical Systems Announces Progress with Guidewire-Compatible Catheter Design and Provides Update on Atherectomy Trial Enrollment

NEW YORK, June 14, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Ra Medical Systems, Inc. (NYSE American: RMED). If you are a shareholder of Ra Medical Systems, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: http://pjlfirm.com/ra-medical-systems-inc/ You may also contact Robert H.

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ra Medical Systems, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

Aclaris Therapeutics

CureVac B.V

Hookipa Pharma Inc

Jiuzi Holdings

The stock prices of RMED, HOOK, JZXN, ACRS, OPRA, and CVAC have fallen noticeably today. These are the details.

RMED, HOOK, JZXN, ACRS, OPRA, CVAC Stock Prices Fall Intraday

GCM Grosvenor Inc

International Money Express Inc.

Royce Investment Partners revealed earlier this week it reduced one position, added to another and sold out of a holding in May.

Chuck Royce's Firm Makes Changes to 3 Positions in May

Ra Medical Systems Inc. (NYSE:RMED) shares jumped higher Monday after retail traders pushed the stock higher. The stock was likely pushed as a possible short squeeze as it had a very high percentage of short sellers in the stock.

Why Did Ra Medical Systems Skyrocket Today?

RA Medical (RMED) stock is rocketing higher on Monday as retail traders on Reddit seek out their next target to send soaring. The post RMED Stock: 8 Things to Know About RA Medical as Retail Investors Look for the Next AMC appeared first on InvestorPlace.

RMED Stock: 8 Things to Know About RA Medical as Retail Investors Look for the Next AMC

RA Medical Systems Inc (NYSE:RMED) is shooting out of penny stock territory this morning, up 65.2% at $8.06 at last check, as the heavily shorted stock looks to be one of the latest victims of the "meme" stock craze.

Breaking Down Recent Reddit Target, RMED

The stock price of RA Medical Systems Inc (NYSEAMERICAN: RMED) increased by over 50% pre-market. This is why it happened.

RMED Stock Price: Over 50% Increase Pre-Market Explanation

Alset EHome International

Sequential Brands Group

Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.

3 Short Squeeze Candidates Trading Under $10

The stock price of Ra Medical Systems, Inc. (NYSE American: RMED) increased by over 25% during intraday trading. This is why it happened.

RMED Stock: Over 25% Increase Intraday Explanation

Second Sight Medical Products

Lucira Health

Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallies On Positive Results For Visual Prosthesis: Second Sight, which makes implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced two-year results for the early feasibility study of its Orion Visual Cortical Prosthesis.

Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2021 Results - Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three months ended March 31, 2021 and provides a business update. Recent Operational Highlights Enrolled 20 subjects in the company's atherectomy pivotal clinical study since mid-March for a total of 50 subjects enrolled to date Completed in-house real time ag

News for Ra Medical Systems Inc Stock (RMED)